APRIL/TNFSF13 Monoclonal Antibody
- Size: 100ul
- Application: WB, IF(ICC)
- Reactivity: Human, Mouse, Rat
- Predicted Reactivity:
-
Datasheet Tech Support
IMAGES
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
APRIL/TNFSF13 Monoclonal Antibody |
CONJUGATION |
Unconjugated |
HOST |
Rabbit |
SOURCE |
Synthetic Peptide within Human APRIL/TNFSF13 aa 150-250. |
IMMUNOGEN RANGE |
|
CLONALITY |
Monoclonal |
ISOTYPE |
IgG |
CONCENTRATION |
1ug/ul |
PURIFICATION |
Purified by Protein A. |
STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
STORAGE CONDITION |
Store at -20°C for 12 months.. |
TARGET |
|
---|---|
GENE ID |
|
SUBCELLULAR LOCATION |
Secreted |
SYNONYMS |
A proliferation inducing ligand antibody, A proliferation-inducing ligand antibody, APRIL antibody, CD256 antibody, TALL-2 antibody, TALL2 antibody, TNF related death ligand antibody, TNF- and APOL-related leukocyte expressed ligand 2 antibody, TNF-related death ligand 1 antibody, TNF13_HUMAN antibody, TNFSF13 antibody, TRDL-1 antibody, TRDL1 antibody, Tumor necrosis factor (ligand) superfamily, member 13 antibody, Tumor necrosis factor ligand superfamily member 13 antibody, Tumor necrosis factor like protein ZTNF2 antibody, Tumor necrosis factor related death ligand 1 antibody, UNQ383/PRO715 antibody, ZTNF2 antibody |
BACKGROUND |
Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes. |
APPLICATION DILUTION |
WB(1:300-1000), IF(ICC)(1:50-200) |